Prescription drug · ANDA
Modafinil NDC 51407-960
Modafinil 100 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-960-30 | 51407096030 | 30 TABLET in 1 BOTTLE (51407-960-30)Marketed from Oct 28, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Modafinil
- Generic name (nonproprietary)
- modafinil
- Active ingredients
- Modafinil — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209966
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
- Identifiers
- Product ID 51407-960_4576611e-9fb5-b7a8-e063-6294a90a4461SPL ID 4576611e-9fb5-b7a8-e063-6294a90a4461SPL set ID 457662d8-b95c-d3af-e063-6294a90a883eRxCUI 205324, 260218UNII R3UK8X3U3D
- Pharmacologic class
- Sympathomimetic-like Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407096030followed by a unit qualifier and the quantityPackage 51407-0960-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil for excessive sleepiness. Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209966
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Modafinil | Modafinil 200 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-991 |
| Modafinil | Modafinil 100 mg/1 | TabletOral | ASCLEMED USA INC. | 87063-308 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | ASCLEMED USA INC. | 87063-309 |
| Modafinil | Modafinil 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-976 |
| Modafinil | Modafinil 100 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-005 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-961 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-006 |
| Modafinil | Modafinil 100 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1051 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1052 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | Proficient Rx LP | 82804-126 |
| Modafinil | Modafinil 200 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-873 |